Biotech

All Articles

Basilea ratings $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's job cultivating brand new antifungals has gotten a considerable boost from ...

Capricor offers Europe rights to late-stage DMD treatment for $35M

.Possessing already gathered up the USA legal rights to Capricor Rehabs' late-stage Duchenne muscle ...

FDA junks adcomm for Applied's uncommon health condition medication

.After pushing the selection date for Applied Rehabs' metabolic condition medicine govorestat, the F...

Novo inks $600M NanoVation bargain to research hereditary medicines ex-liver

.Novo Nordisk is continuing its press right into hereditary medications, consenting to pay NanoVatio...

Innovent links cytokine to intestines cancer feedbacks

.Innovent Biologics has produced the instance that its gate inhibitor-cytokine fusion protein posses...

Merck, Daiichi ADC attacks target in phase 3 lung cancer cells research

.A stage 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina grows AI concentrate with collab to choose cancer aim ats

.5 months after Rakovina Therapies turned toward expert system, the cancer-focused biotech has actua...

Ascendis' dwarfism medicine smash hits in phase 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a possible threat to BioMarin's Voxzogo, reporting phase 3 ...

Despite ph. 3 overlook, Alkeus finds course ahead of time for eye condition property

.Though Alkeus Pharmaceuticals' dental eye disease property failed to substantially lower geographic...

Kairos goes social along with $6M IPO to finance tests of cancer cells medication

.Along with a triad of biotechs striking the Nasdaq on Friday, it was very easy to overlook a smalle...